Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for NeoCore Technology Co., Ltd. (4131:TWSE), powered by AI.
NeoCore Technology Co., Ltd. is currently trading at $37.90. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for NeoCore Technology Co., Ltd. on Alpha Lenz.
NeoCore Technology Co., Ltd.'s P/E ratio is -30.7.
“NeoCore Technology Co., Ltd. trades at a P/E of -30.7 (undervalued) with modest ROE of -14.7%.”
Ask for details →NeoCore Technology Co., Ltd. is a biotechnology company specializing in the research, development, and manufacturing of biochips and advanced diagnostic solutions. Its primary function is to provide innovative products for food safety testing, human diagnostics, agricultural analysis, and laboratory automation, supporting sectors such as healthcare, biotechnology, and food safety. With a diverse portfolio that includes DNA/RNA sample preparation kits, polymerase chain reaction kits, rapid hybridization devices, and various biomedical reagents, NeoCore Technology enables efficient and accurate biological detection and analysis. The company also extends its reach through the wholesale and retail of contact lenses and various laboratory planning and design services. Founded in 1987 and headquartered in Tainan, Taiwan, NeoCore Technology plays a significant role in both domestic and regional markets, serving clients throughout Asia and Europe. The company's focus on biotechnology innovation supports advancements in medical diagnostics and bioanalysis, positioning it as a specialized player in the medical and biotechnology industries.
“NeoCore Technology Co., Ltd. trades at a P/E of -30.7 (undervalued) with modest ROE of -14.7%.”
Ask for details →NeoCore Technology Co., Ltd. (ticker: 4131) is a company listed on TWSE in the Healthcare sector (Biotechnology). Market cap is $1.5B.
The current price is 37.9 with a P/E ratio of -30.71x and P/B of 4.84x.
ROE is -14.75% and operating margin is -123.22%. Annual revenue is $62M.